Skip to main content
Erschienen in: Journal of Endocrinological Investigation 10/2023

26.03.2023 | Original Article

Morning serum cortisol role in the adrenal insufficiency diagnosis with modern cortisol assays

verfasst von: A. F. D. Fragoso Perozo, R. Fontes, F. P. Lopes, P. B. Araújo, Y. Scrank, D. M. V. Gomes, A. B. Moraes, L. Vieira Neto

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the accuracy of cutoff values of the morning serum cortisol (MSC) using the cortisol stimulus test (CST) insulin tolerance test (ITT) and 250 mcg short Synacthen test (SST) as the reference standard tests, to better define its clinical role as a tool in the diagnostic investigation of adrenal insufficiency (AI) AI.

Methods

An observational study was conducted with a retrospective analysis of MSC in adult patients who had been submitted to a CST to investigate AI between January 2014 and December 2020. The normal cortisol response (NR) to stimulation was defined based on the cortisol assay.

Results

371 patients underwent CST for suspected AI, 121/371 patients (32.6%) were diagnosed with AI. ROC curve analysis showed an area under the curve (AUC) for MSC of 0.75 (95% CI 0.69 – 0.80). The best MSC cutoff values to confirm AI were < 3.65, < 2.35 and < 1.5 mcg/dL with specificity of 98%, 99%, and 100%, respectively. MSC > 12.35, > 14.2 and > 14.5 mcg/dL had sensitivity of 98%, 99%, and 100%, respectively, being the best cutoff values to exclude AI. Almost 25% of patients undergoing CST for possible AI had MSC values between < 3.65 mcg/dL (6.7% of patients) and > 12.35 mcg/dL (17.5% of patients), making the formal CST testing unnecessary if we consider these cutoff values.

Conclusion

With the most modern cortisol assays, MSC could be used as a diagnostic tool, with high accuracy to confirm or exclude AI, avoiding unnecessary CST; thus, reducing expenses and safety risks during AI investigation.
Literatur
1.
Zurück zum Zitat On the Constitutional and Local Effects of Disease of the Supra-Renal Capsules (1856). Br Foreign Med Chir Rev 18(36): 404–413. On the Constitutional and Local Effects of Disease of the Supra-Renal Capsules (1856). Br Foreign Med Chir Rev 18(36): 404–413.
8.
Zurück zum Zitat Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ (2016) Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(2):364–389. https://doi.org/10.1210/jc.2015-1710CrossRefPubMed Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ (2016) Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(2):364–389. https://​doi.​org/​10.​1210/​jc.​2015-1710CrossRefPubMed
14.
Zurück zum Zitat Schmidt IL, Lahner H, Mann K, Petersenn S (2003) Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. J Clin Endocrinol Metab 88(9):4193–4198. https://doi.org/10.1210/jc.2002-021897CrossRefPubMed Schmidt IL, Lahner H, Mann K, Petersenn S (2003) Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. J Clin Endocrinol Metab 88(9):4193–4198. https://​doi.​org/​10.​1210/​jc.​2002-021897CrossRefPubMed
15.
Zurück zum Zitat Kazlauskaite R, Evans AT, Villabona CV, Abdu TA, Ambrosi B, Atkinson AB, Choi CH, Clayton RN, Courtney CH, Gonc EN, Maghnie M, Rose SR, Soule SG, Tordjman K, Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency (2008) Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metab 93(11):4245–4253. https://doi.org/10.1210/jc.2008-0710CrossRefPubMed Kazlauskaite R, Evans AT, Villabona CV, Abdu TA, Ambrosi B, Atkinson AB, Choi CH, Clayton RN, Courtney CH, Gonc EN, Maghnie M, Rose SR, Soule SG, Tordjman K, Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency (2008) Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metab 93(11):4245–4253. https://​doi.​org/​10.​1210/​jc.​2008-0710CrossRefPubMed
18.
Zurück zum Zitat Sbardella E, Isidori AM, Woods CP, Argese N, Tomlinson JW, Shine B, Jafar-Mohammadi B, Grossman AB (2017) Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays. Clin Endocrinol 86(2):177–184. https://doi.org/10.1111/cen.13232CrossRef Sbardella E, Isidori AM, Woods CP, Argese N, Tomlinson JW, Shine B, Jafar-Mohammadi B, Grossman AB (2017) Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays. Clin Endocrinol 86(2):177–184. https://​doi.​org/​10.​1111/​cen.​13232CrossRef
19.
Zurück zum Zitat Struja T, Briner L, Meier A, Kutz A, Mundwiler E, Huber A, Mueller B, Bernasconi L, Schuetz P (2017) Diagnostic accuracy of basal cortisol level to predict adrenal insufficiency in cosyntropin testing: results from an observational cohort study with 804 patients. Endocr Pract: Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 23(8):949–961. https://doi.org/10.4158/EP171861.ORCrossRef Struja T, Briner L, Meier A, Kutz A, Mundwiler E, Huber A, Mueller B, Bernasconi L, Schuetz P (2017) Diagnostic accuracy of basal cortisol level to predict adrenal insufficiency in cosyntropin testing: results from an observational cohort study with 804 patients. Endocr Pract: Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 23(8):949–961. https://​doi.​org/​10.​4158/​EP171861.​ORCrossRef
21.
Zurück zum Zitat Mackenzie SD, Gifford RM, Boyle LD, Crane MS, Strachan M, Gibb FW (2019) Validated criteria for the interpretation of a single measurement of serum cortisol in the investigation of suspected adrenal insufficiency. Clin Endocrinol 91(5):608–615. https://doi.org/10.1111/cen.14071CrossRef Mackenzie SD, Gifford RM, Boyle LD, Crane MS, Strachan M, Gibb FW (2019) Validated criteria for the interpretation of a single measurement of serum cortisol in the investigation of suspected adrenal insufficiency. Clin Endocrinol 91(5):608–615. https://​doi.​org/​10.​1111/​cen.​14071CrossRef
22.
24.
Zurück zum Zitat El-Farhan N, Pickett A, Ducroq D, Bailey C, Mitchem K, Morgan N, Armston A, Jones L, Evans C, Rees DA (2013) Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays. Clin Endocrinol 78(5):673–680. https://doi.org/10.1111/cen.12039CrossRef El-Farhan N, Pickett A, Ducroq D, Bailey C, Mitchem K, Morgan N, Armston A, Jones L, Evans C, Rees DA (2013) Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays. Clin Endocrinol 78(5):673–680. https://​doi.​org/​10.​1111/​cen.​12039CrossRef
Metadaten
Titel
Morning serum cortisol role in the adrenal insufficiency diagnosis with modern cortisol assays
verfasst von
A. F. D. Fragoso Perozo
R. Fontes
F. P. Lopes
P. B. Araújo
Y. Scrank
D. M. V. Gomes
A. B. Moraes
L. Vieira Neto
Publikationsdatum
26.03.2023
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 10/2023
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-023-02062-y

Weitere Artikel der Ausgabe 10/2023

Journal of Endocrinological Investigation 10/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.